Disclosure! These peptides have not been evaluated by the FDA. These peptides are not a form of medication and are for research purposes only. Purchasing research peptides for personal use is illegal.

Tirzepatide is a once-weekly injectable drug that is used to treat type 2 diabetes and obesity. It is an analogue of GIP, a hormone that stimulates insulin release, and a receptor agonist of both GIP and GLP-1, another hormone that regulates blood sugar and weight⁵⁴. Tirzepatide is approved by the FDA for improving blood sugar control in adults with Type 2 diabetes

Lyophilized powder form, intended solely for laboratory use and not for human consumption.